Press Releases
Video News Releases
General Media Information
Photography Services
Communications Staff
Public Events
Emory in the News
Press Kits
Honors and Awards
Expert List

Media Contact: Holly Korschun 10 May 2007    
  (404) 727-3990   Print  | Email ]

Emory Names New Executive Directors to Enhance Clinical Trials Office
Emory University School of Medicine has appointed two new administrators for its Clinical Trials Office with the overall aim of improving efficiency and making more clinical trials available for patients. The new appointments, effective May 1, 2007, are part of an ongoing initiative at Emory to invest more resources in research infrastructure and quality improvement.

Robin C. Ginn has been named executive director of the Clinical Trials Office and S. David McLean, Jr., has been named associate executive director. The two new directors will work to expand capacity for clinical trials, centralize business functions in the Clinical Trials Office to compress the timeline in handling of clinical trials, and improve efficiency. McLean will have a particular focus on directing clinical trial "pre-awards," which involves budget negotiation and analysis of Medicare coverage to ensure appropriate billing.

Ginn has worked in health care for 27 years, including eight years in critical care nursing and management and eight years in project management in hospital information systems (both clinical and financial). She comes to Emory from Vanderbilt University Medical Center, where she most recently was executive director of research informatics and regulatory affairs. In that position she was responsible for oversight and fiscal responsibility of departments that support clinical research. She assimilated Vanderbilt's clinical research services into a virtual one-stop shopping network for investigators by unifying compartmentalized functions under a common, service-oriented institutional goal.

In her prior position at Vanderbilt as director of research informatics and regulatory affairs, Ginn restructured the Institutional Review Board from an underperforming operation into a highly effective, state-of-the-art department with significant improvements in efficiency, investigator satisfaction, increased performance standards, and expanded clinical trials volume.

She received her bachelor's degree in nursing from Southern Illinois University and her MBA in management from Lindenwood College in St. Louis.

McLean is an Atlanta attorney with 17 years of corporate health care experience with several Atlanta law firms, representing hospitals, healthcare systems, and physician practice management companies regarding corporate and regulatory health care issues, regulatory compliance, and reimbursement issues. He has extensive experience representing hospitals and research groups with regard to the conduct of clinical research. He also served as administrator of the Institutional Review Board (IRB) at Saint Joseph's Hospital of Atlanta.

He received his undergraduate degree from Washington & Lee University and his J.D. degree from Emory University School of Law. He is a frequent speaker on topics of health care compliance and regulation, health care fraud and abuse, medical malpractice, patients' rights and health care law.

"As an academic health center, Emory University's Woodruff Health Sciences Center places a very high value on conducting human clinical research studies of the highest quality for the benefit of our patients and for the advancement of medical science," says David Stephens, MD, executive associate dean for research in Emory University School of Medicine. "The recruitment of these two outstanding individuals will enhance the quality and efficiency of our clinical trials program and allow us to offer more research studies."

<<::Back to Press Releases

About Us | Education | Patient Care | Research | News & Publications Site Map  

Copyright © Emory University, 2022. All Rights Reserved.